LEPR and breast carcinoma: Liu and Liu (2011) in a meta-analysis based on three studies with 2,003 cases and 1,967 controls revealed for LEP rs7799039G>A polymorphism and nine studies with 4,627 cases and 5,476 controls for LEPR rs1137101 revealed that these polymorphisms were not associated with breast cancer risk.